Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Bridging the Brain Disease Knowledge Gap Through Computational Modeling and Systems Biology
The Submaximal Clinical Exercise Tolerance Test (SXTT) to Establish Safe Exercise Prescription Parameters for Patients with Chronic Disease and Disability.
Correlates of Executive Functions in Multiple Sclerosis Based on Structural and Functional MR Imaging: Insights from a Multicenter Study.
Modulation of Sox10, HIF-1α, Survivin, and YAP by Minocycline in the Treatment of Neurodevelopmental Handicaps following Hypoxic Insult.
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.
New data at ENS show Novartis drug Gilenya benefited patients by improving all four key measures of multiple sclerosis
Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex.
Vitamin D3 Receptor ( VDR ) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis.
Teva and Takeda announce agreement for glatiramer acetate for multiple sclerosis treatment in Japan
Imaging In The Cell
Association mapping of disease loci, by use of a pooled DNA genomic screen.
"Tell me what you want, what you really really want….": asking people with multiple sclerosis about enhancing their participation in physical activity.
In vitro Biological Characterization of IFN-β-1a major Glycoforms.
Nerve Conduction Velocity Is Regulated by the Inositol Polyphosphate-4-Phosphatase II Gene.
Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.
[Vitamin D for prevention of diseases?].
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
On dihydroorotate dehydrogenases, their inhibitors and uses.
Unraveling the secrets of white matter - Bridging the gap between cellular, animal and human imaging studies.
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.
Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial.
Reproductive issues in women with multiple sclerosis: ethical considerations.
1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
Pages
« first
‹ previous
…
154
155
156
157
158
159
160
161
162
…
next ›
last »